Mark L. Baum

Mark L. Baum

Chief Executive OfficeratHarrow· In proxies 2022–2025

Pay in FY2025+1,638% from the year before · Harrow stock +46.1% the same year

Mark L. Baum was paid $23.6M in FY2025 (Dec), up 1,638%. Harrow stock rose 46.1% that year.

Pay$100 in the stock at the end of FY21 → $567
Pay is from the Summary Compensation Table of each Harrow proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. HarrowPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role +224%
  2. Eton Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Ideal Power, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Melt Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Surface Ophthalmics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?